Prof. Dr. med. Clemens Kaiser
Sektionsleiter Mammadiagnostik UMM
Curriculum Vitae
Prof. Dr. med. Clemens Kaiser
Dipl. Kfm. (EMA), B.A.
Sektionsleiter Mammadiagnostik
Oberarzt in der Klinik für Radiologie und Nuklearmedizin, Universitätsmedizin Mannheim
Klinische Schwerpunkte
- Multimodale Mammadiagnostik
- MR-Mammographie
Wissenschaftliche Tätigkeit
Juni 2019
Habilitation im Fach Radiologie zum Thema “Optimierung der MR-Mammographie auf ihrem Weg zur Screening-Methode” (Venia legendi)
Jan. 2017 – Mai 2017
Forschungsrotation am Deutschen Krebsforschungszentrum (DKFZ) in Heidelberg
Jul. 2013 – Okt. 2013
Forschungsrotation am Institut für diagnostische und interventionelle Radiologie der Friedrich-Schiller-Universität Jena
Nov. 2010
Dissertation an der Friedrich-Schiller-Universität Jena (09.11.2010). Thema „Duct-Obstruction-Sign – Gangektasie zur Abklärung der Differentialdiagnose DCIS versus Papillom in der MR-Mammographie“. Doktorvater: Prof. Dr. med. Pascal Baltzer (Gesamtprädikat: Magna cum laude).
Weitere Tätigkeiten und Qualifikationen
Dez. 2016
Baden-Württemberg Zertifikat für Hochschuldidaktik in der Medizin (MQ 1 & 2)
Tätigkeit als Gutachter von wissenschaftlichen Fachzeitschriften
- European Radiology
- Investigative Radiology
- Academic Radiology
- European Journal of Radiology
Mitgliedschaften in Fachgesellschaften
Seit 2016
Deutsche Gesellschaft für Ultraschall in der Medizin (Degum)
Seit 2011
Deutsche Röntgengesellschaft (DRG)
Seit 2011
Radiological Society of North America (RSNA)
Seit 2011
European Society of Radiology (ESR)
Erfahrungen in klinischen Studien
Principal investigator
USCT (https://www.ipe.kit.edu/projekte_2833.php)
Principal investigator
MA-DETECT (https://brustkrebs-vorsorge-mrt.de)
1. Axillary lymph node characterization in breast cancer patients using magnetic resonance mammography: a prospective comparative study with FDG PET-CT and healthy women.
J. Krammer, K. Wasser, A. Schnitzer, T. Henzler, S. Schoenberg, Kaiser CG. Eur J Radiol. 2013;82:2194–2198.
Impact factor: 2,518
2. Is “prepectoral edema” a morphologic sign for malignant breast tumors?
CG. Kaiser, M. Herold, P. Baltzer, M. Dietzel, J. Krammer, M. Gajda, O. Camara, S.O. Schoenberg, W.A. Kaiser, K. Wasser. Acad Radiol. 22 (2015) 684–689.
Impact factor: 1,966
3. Magnetic resonance imaging of intraductal papillomas: typical findings and differential diagnosis
M. Dietzel, C.G. Kaiser*, P. Baltzer. J Comput Assist Tomogr. 39 (2015) 176–184.
Impact factor: 1,470
4. DCE-MRI of the breast in a stand-alone setting outside a complementary strategy - results of the TK-study.
C.G. Kaiser, C. Reich, M. Dietzel, P. a. T. Baltzer, J. Krammer, K. Wasser, S.O. Schoenberg, W.A. Kaiser. Eur Radiol. 25 (2015) 1793–1800.
Impact factor: 3,64
5. Focal transitional mastitis in MR-mammography: preliminary findings.
C.G. Kaiser*, M. Dietzel, P. Baltzer, A. Kaiser, T. Henzler, W. A. Kaiser, J. Krammer. European Journal of Radiology Open 3 (2016): 117–22.
Impact factor: 3,528
6. The value of “constant sharpness” as a diagnostic sign in MR-Mammography.
C. G. Kaiser, P. Baltzer, A.K. Kaiser, J. Krammer, M. Uder, W.A. Kaiser, M. Dietzel. Eur J Radiol Open. 3 (2016) 236–238.
Impact factor: 3,52
7. Differentiation of ductal carcinoma in situ versus fibrocystic changes by magnetic resonance imaging: are there pathognomonic imaging features?
M. Dietzel, C.G. Kaiser*, E. Wenkel, P. Clauser, M. Uder, R. Schulz-Wendtland, P.A. Baltzer. Acta Radiol. (2017) 284185117690420.
Impact factor: 2,009
8. Prognostic Value of “Prepectoral Edema” in MR-Mammography.
C.G. Kaiser, M. Herold, J. Krammer, P. Baltzer, M. Gajda, O. Camara, S. Schoenberg, W.A. Kaiser, M. Dietzel. Anticancer Res. 37 (2017) 1989–1995.
Impact factor: 1.895
9. The Assessment of Background Parenchymal Enhancement (BPE) in a High-Risk Population: What Causes BPE?
C. You, A. K. Kaiser, P. Baltzer, J. Krammer, Y. Gu, W. Peng, S. Schoenberg, C.G. Kaiser. Translational Oncology 11, Nr. 2 (2018): 243–49.
Impact factor: 3,025
10. Value of ductal obstruction sign in the differentiation of benign and malignant breastlesions at MR imaging
P.A.T. Baltzer, C.G. Kaiser, M. Dietzel, T. Vag, A.B. Herzog, M. Gajda, O. Camara, W.A. Kaiser, Eur J Radiol. 2010; 75:e18–e21.
Impact factor: 2,518
11. Combined reading of Contrast Enhanced and Diffusion Weighted Magnetic Resonance Imaging by using a simple sum score
A. Baltzer, M. Dietzel, C.G. Kaiser, P.A. Baltzer, Eur Radiol. (2015)
Impact factor: 3,64
12. Perirenal Edema as a potential hint towards primary hypertension-Preliminary findings in MRI breast cancer staging
C.G. Kaiser, P. Baltzer, A.K. Kaiser, J. Knaudt, T. Henzler, W.A. Kaiser, M. Dietzel. Eur J Radiol Open. 3 (2016) 123–126.
Impact factor: 3,528
13. Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study.
Froelich MF, Kaiser CG (2020) Eur Radiol 31:967–974.
Impact factor: 5.315
14. Cost-effectiveness of MR-Mammography vs. conventional Mammography in screening patients at intermediate risk of breast cancer - A model-based economic evaluation.
Kaiser CG, Dietzel M, Vag T, Froelich MF (2020) Eur J Radiol 136:109355.
Impact factor: 2.687
15. Impact of specificity on cost-effectiveness of screening women at high risk of breast cancer with magnetic resonance imaging, mammography and ultrasound.
Kaiser CG, Dietzel M, Vag T, Ruebenthaler J, Froelich M, Tollens F (2021) Eur J Radiol 137:109576.
Impact factor: 2.687
16. Cost-Effectiveness of Digital Breast Tomosynthesis vs. Abbreviated Breast MRI for Screening Women with Intermediate Risk of Breast Cancer—How Low-Cost Must MRI Be?
Tollens F, Baltzer PAT, Dietzel M, Ruebenthaler J, Froelich M, Kaiser CG (2021) Cancers 13:1241.
Impact factor: 6.639
17. T2-weighted Imaging of the Breast at 1.5T Using Simultaneous Multi-slice Acceleration.
Riffel J, Kannengiesser S, Schoenberg SO, Overhoff D, Riffel P, Kaiser CG (2021) Anticancer Res 41:4423–4429.
Impact factor: 2.480
18. Cost-Effectiveness of MR-Mammography in Breast Cancer Screening of Women With Extremely Dense Breasts After Two Rounds of Screening.
Tollens F, Baltzer PAT, Dietzel M, Kunz W, Ruebenthaler J, Froelich M, Kaiser CG (2021) Frontiers in Oncology 11:3449.
Impact factor: 6.244
19. Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
Clauser P, Dietzel M, Weber M, Kaiser CG, Baltzer PAT (2019) Acta Radiol 60:19–27.
Impact factor: 1,603
20. Cost-effectiveness analysis in radiology: methods, results and implications.
Froelich MF, Kunz WG, Tollens F, Schnitzer ML, Schoenberg SO, Kaiser CG, Ruebenthaler J, Rofo. (2021)
Impact factor: 1,867
